Crystal Structure of 2-(Pyridin-4-yl)-5-(Undecylthio)-1,3,4-Oxadiazole


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The title compound 2-(pyridin-4-yl)-5-(undecylthio)-1,3,4-oxadiazole (C18H27ON3S) is synthesized, and its structure is confirmed by 1H NMR, MS, elemental analyses and X-ray diffraction. It crystallizes in the monoclinic system, space group P2(1)/c with a = 24.453(17) Å, b = 10.604(7) Å, c = 7.095(5) Å, β = 91.60(2)°, V = 1839(2) Å3, Z = 4, and R = 0.086 for 2295 observed reflections with I > 2σ(I). The preliminary biological test shows that the title compound has good activity against Pythium ultimum with inhibitory to be 77.78%.

About the authors

Z.-H. Shen

College of Chemical Engineering

Email: xhliu@zjut.edu.cn
China, Hangzhou, Zhejiang

Q. Wang

College of Chemical Engineering

Email: xhliu@zjut.edu.cn
China, Hangzhou, Zhejiang

Z.-H. Sun

College of Chemical Engineering

Email: xhliu@zjut.edu.cn
China, Hangzhou, Zhejiang

H.-K. Wu

College of Chemical Engineering

Email: xhliu@zjut.edu.cn
China, Hangzhou, Zhejiang

C.-X. Tan

College of Chemical Engineering

Email: xhliu@zjut.edu.cn
China, Hangzhou, Zhejiang

J.-Q. Weng

College of Chemical Engineering

Email: xhliu@zjut.edu.cn
China, Hangzhou, Zhejiang

X.-H. Liu

College of Chemical Engineering

Author for correspondence.
Email: xhliu@zjut.edu.cn
China, Hangzhou, Zhejiang

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Pleiades Publishing, Ltd.